Qrono Inc. --
Use tab to navigate through the menu items.
Patients Need Effective Cancer Treatment
Current immunotherapies only help niche patient populations.
Qrono sees hope from an immunoengineering approach
Advancing cancer therapy at the interface of engineering and immunology
Eloquent™ Immunotherapy rewrites tumor-immune cell communication